Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horatiu Olteanu

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Pathology|August 8, 2022
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined SignificanceDragan Jevremovic, Ahmad Nanaa, Susan M Geyer, et al.
American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.
Blood Cancer Journal|March 13, 2023
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, et al.
Blood Cancer Journal|January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myelomaSaurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood Cancer Journal|January 26, 2022
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patientsRong He, Jonathan Chiou, Allison Chiou, et al.
Blood Cancer Journal|February 18, 2025
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myelomaSaurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2017
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative StudyMohamed A Kharfan-Dabaja, Renju Raj, Liana Nikolaenko, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
American Journal of Clinical Pathology|September 2, 2023
Superior detection rate of plasma cell FISH using FACS-FISHMarie-France Gagnon, Sally M Midthun, James A Fangel, et al.
Blood Cancer Journal|September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomesTamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Pathology|August 8, 2022
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined SignificanceDragan Jevremovic, Ahmad Nanaa, Susan M Geyer, et al.
American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.
Blood Cancer Journal|March 13, 2023
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, et al.
Blood Cancer Journal|January 3, 2026
Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myelomaSaurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Blood Cancer Journal|January 26, 2022
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patientsRong He, Jonathan Chiou, Allison Chiou, et al.
Blood Cancer Journal|February 18, 2025
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myelomaSaurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2017
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative StudyMohamed A Kharfan-Dabaja, Renju Raj, Liana Nikolaenko, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
American Journal of Clinical Pathology|September 2, 2023
Superior detection rate of plasma cell FISH using FACS-FISHMarie-France Gagnon, Sally M Midthun, James A Fangel, et al.
Blood Cancer Journal|September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomesTamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Pageof 12